ADAGE CAPITAL PARTNERS GP L.L.C. 13D and 13G filings for Fulcrum Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-07 07:44 am Sale | 2023-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,506,422 2.440% | -1,964,125 (-56.59%) | Filing |
| 2023-03-06 4:40 pm Purchase | 2023-02-24 | 13G | Fulcrum Therapeutics, Inc. FULC | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,470,547 5.630% | 2,350,547 (+209.87%) | Filing |
| 2023-02-09 11:39 am Sale | 2022-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,120,000 2.150% | -1,030,000 (-47.91%) | Filing |
| 2022-03-10 4:30 pm Purchase | 2022-02-28 | 13G | Fulcrum Therapeutics, Inc. FULC | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,150,000 5.290% | 2,150,000 (New Position) | Filing |